ADVM-022 Intravitreal Gene Therapy for DME

NCT04418427 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Macular Edema
Diabetic Retinopathy

Interventions

BIOLOGICAL: 6E11 vg/eye of ADVM-022
BIOLOGICAL: 2E11 vg/eye of ADVM-022
BIOLOGICAL: Aflibercept

Sponsor

Adverum Biotechnologies, Inc.